XX, H., LY, Z., & RY, L. (2023). The association between the serum concentration of CXC subfamily chemokine 13 and post-surgical clinical outcomes in cervical cancer patients. European review for medical and pharmacological sciences, 27(23), 11635. https://doi.org/10.26355/eurrev_202312_34601
Chicago Style (17th ed.) CitationXX, Hu, Zhou LY, and Lin RY. "The Association Between the Serum Concentration of CXC Subfamily Chemokine 13 and Post-surgical Clinical Outcomes in Cervical Cancer Patients." European Review for Medical and Pharmacological Sciences 27, no. 23 (2023): 11635. https://doi.org/10.26355/eurrev_202312_34601.
MLA (9th ed.) CitationXX, Hu, et al. "The Association Between the Serum Concentration of CXC Subfamily Chemokine 13 and Post-surgical Clinical Outcomes in Cervical Cancer Patients." European Review for Medical and Pharmacological Sciences, vol. 27, no. 23, 2023, p. 11635, https://doi.org/10.26355/eurrev_202312_34601.